Abstract Body

Background: HIV Elite Controllers (ECs) spontaneously control viral load. Some EC however initiate anti-retroviral treatment (cART), due to loss of viral control or CD4 T cell (CD4Tc) decrease. The CD4Tc dynamics in Controllers on cART has been poorly described. Here we studied the CD4Tc dynamics after cART initiation among 34 EC followed in US and Europe cohorts, compared to viremic infected patients (VIRs). Methodology: ECs were defined as having ≥ 5 viral load (VL) measurements <400 copies/mL over ≥5 years while never having received ART and were identified from the French ANRS CO18 Cohort, the US SCOPE Cohort, the International HIV Controllers study and the European CASCADE collaboration. VIRs were selected from the ANRS COPANA Cohort which enrols ART-naive recently-diagnosed (<1 year) HIV-1-infected adults. Dynamics of CD4Tc counts after cART initiation were modelled by piecewise mixed linear models. Results: In VIRs, CD4Tc increase after cART initiation followed a 2-stage pattern: an initial rapid increase over the first 3 months (+0.63 sqrt(CD4)/ month), followed by a slower increase of +0.19 sqrt(CD4)/month. This contrast with treated ECs where no such rapid first slope was observed: the CD4 increase was moderate and similar to the second slope observed in VIRs. For a patient starting cART at 300 CD4Tc, mean gain in the first 12 months were 139 for VIRs vs. only 80 for ECs (p=0.048). Conclusions: This is the largest series of treated ECs. ECs who initiate cART experience an increase in CD4Tc counts, although lower than that achieved by VIRs.